3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Thrombocytosis
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Cytarabine
85
Cyclophosphamide
58
Azacitidine
57
fludarabine
52
venetoclax
41
fludarabine phosphate
41
Busulfan
30
Filgrastim
23
Whole-Body Irradiation
22
Decitabine
21
Mycophenolic Acid
20
Methotrexate
19
Mitoxantrone
18
Etoposide
18
Antilymphocyte Serum
18
Cyclosporine
17
Clofarabine
17
Tacrolimus
16
Granulocyte Colony-Stimulating Factor
16
Peripheral Blood Stem Cell Transplantation
15
Daunorubicin
15
Melphalan
13
thymoglobulin
11
Thiotepa
11
Stem Cell Transplantation
11
Interleukin-2
11
Idarubicin
10
Gemtuzumab
9
Cord Blood Stem Cell Transplantation
9
aldesleukin
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Leukemia, Myeloid, Acute
×
luspatercept
×
Clear all
NCT01688011
2025-07-03
Connect® Myeloid Disease Registry
Celgene
Terminated
2,013 enrolled